新闻中心

News Center

Foncoo Pharmaceutical participated in the 19th National Psychiatry Academic Conference of the Chinese Medical Association

Release Time

2022-06-21 15:34

Sponsored by the Chinese Medical Association and the Psychiatry Branch of the Chinese Medical Association, and organized by the Chongqing Medical Association, the Psychiatry Branch of the Chongqing Medical Association, the First Affiliated Hospital of Chongqing Medical University, and the University City Hospital Affiliated to Chongqing Medical University The conference and the Academic Conference on Child and Adolescent Psychiatry were successfully held at Chongqing Yuelai International Conference Center from December 21 to 24, 2021.

The main venue of the 19th National Psychiatry Academic Conference of the Chinese Medical Association (on-site)

 

The theme of this conference is "Psychiatry in the Age of Brain Science". The form and content of this academic conference are rich and colorful, and 166 conferences were actually held by combining online and offline methods. Nearly 1,600 people attended the conference in Chongqing. During the conference, the cumulative number of views and views of the participants and the anonymous visitors was nearly 1 million. Pangu Pharmaceutical held a satellite conference during the conference, attracting about 768 people to watch on-site and online.

 

Agenda

 

Shenzhen Foncoo Pharmaceutical Co., Ltd. is invited to participate in this meeting, and at 12:00-13:30 on December 23, 2021, we are honored to invite Zhao Min, Si Tianmei, Liu Tiebang and Wang Xiaoping. Professor, gave a wonderful presentation on the development status and challenges of psychiatry and new perspectives on antipsychotic drug treatment. There are about 80 people on site, 688 people online, and a total of about 768 people for academic exchange activities at the same time.

 

Professor Zhao Min gave a speech

Professor Si Tianmei delivered a speech

Multi-directional display of company products

 

The participation in this conference promoted the products of our company through the communication of the expert satellite conference and the product display, which further promoted the doctors' understanding of Pangu Pharmaceuticals and related products, and strengthened the cooperation and exchanges between our company and well-known academic platforms. Very good Promote the brand image of the company and products.

Committed to the cause of improving human physical and mental health

Previous page

Previous page

Related News

Foncoo Pharmaceutical participated in the 19th National Psychiatry Academic Conference of the Chinese Medical Association

Sponsored by the Chinese Medical Association and the Psychiatry Branch of the Chinese Medical Association, and organized by the Chongqing Medical Association, the Psychiatry Branch of the Chongqing Medical Association, the First Affiliated Hospital of Chongqing Medical University, and the University City Hospital Affiliated to Chongqing Medical University The conference and the Academic Conference on Child and Adolescent Psychiatry were successfully held at Chongqing Yuelai International Conference Center from December 21 to 24, 2021.

2022-05-25

图片名称

2021-Foncoo Public Welfare

On October 15, 2021, Foncoo Pharmaceutical donated 100,000 yuan in cash to the "Gu Xueqiu Pharmacy Education Fund" public welfare student aid project of the Beijing Renren Public Welfare Foundation-Shenyang Pharmaceutical University.

2022-05-25

图片名称

Foncoo Pharmaceutical's corporate culture 5.0 was officially released

Official announcement! Seriously, don't be distracted!

2022-05-25

图片名称

Foncoo Pharmaceutical participated in the 16th National Academic Conference on Psychiatric Hospital Management

On October 29-31, 2021, the 16th National Academic Conference on Psychiatric Hospital Management, hosted by the Chinese Hospital Association and the Chinese Hospital Association Psychiatric Hospital Branch, was held in Chongqing.

2022-05-25

图片名称

"Bupropion Hydrochloride Sustained-Release Tablets (II)" exclusively sold by Foncoo Pharmaceuticals was approved in China

Recently, "Bupropion Hydrochloride Sustained-Release Tablets (II) (150mg, 300mg)", exclusively sold by Pangu Pharmaceuticals (Mainland China), was approved by the State Drug Administration and deemed to have passed the consistency evaluation. The product, developed by Shanghai Xuantai Pharmaceuticals, was previously approved by the FDA in August 2017 and was marketed in the United States.

2022-05-25

图片名称

Foncoo Pharmaceutical participated in the 9th China Schizophrenia Forum

From October 22 to 24, 2021, the "Ninth China Schizophrenia Forum" was grandly held in Wuhan. The theme of this forum is "Infection, Inflammation and Schizophrenia".

2022-05-25

图片名称